Top Markets
Coin of the day
Theranexus Société Anonyme Theranexus Société Anonyme

Theranexus Société Anonyme

ALTHX
株式のランク #15061
Theranexus société anonyme, a biopharmaceutical company, develops drug... Theranexus société anonyme, a biopharmaceutical company, develops drug candidates for the treatment of central nervous system disorders. The company's lead drug candidate is THN102, which is in Phase II clinical trial to treat sleep/wake disorders. It also develops THN201 for the treatment of neurocognitive disorders linked to Alzheimer's disease; and THN101 to treat neuropathic pain. The company was founded in 2013 and is based in Lyon, France.
株価
$4.66
時価総額
$43.92M
変化(1日)
-0.63%
変化(1年)
338.04%
FR
取引 Theranexus Société Anonyme (ALTHX)

カテゴリー

Theranexus Société Anonyme(ALTHX)のEPS
December 2025 時点のEPS TTM: $-0.26
Theranexus Société Anonymeの最新の財務報告と株価によると、同社の現在のEPS(TTM)は$-0.26です。2023年末には、EPSは$-0.97で、2022年のEPS$-1.33と減少でした。
Theranexus Société AnonymeのEPS履歴(2015から2026まで)
各年末時点のEPS
EPS 変化
2026 (TTM) $-0.26 17.32%
2024 $-0.22 -77.54%
2023 $-0.97 -26.86%
2022 $-1.33 -29.54%
2021 $-1.89 31.35%
2020 $-1.44 -17.37%
2019 $-1.74 -10.98%
2018 $-1.95 139.44%
2017 $-0.82 -56.68%
2016 $-1.88 199.05%
2015 $-0.63 0.00%
同様の企業または競合他社のEPS
企業 EPS EPSの差
$4.36 -1,788.61%
DK
$17.01 -6,690.47%
US
$42.53 -16,578.11%
US
$9.62 -3,827.55%
BE
$26.66 -10,429.33%
NL